Oncolytics Biotech (ONCY) Earnings Date, Estimates & Call Transcripts → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free ONCY Stock Alerts $1.13 +0.02 (+1.80%) (As of 10:31 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (Mar. 7) -$0.04 Beat By $0.07 Consensus EPS (Mar. 7) -$0.11 Get Oncolytics Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for ONCY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueONCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONCY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Oncolytics Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ4 20241($0.04)($0.04)($0.04)20241($0.04)($0.04)($0.04)Q1 20252($0.09)($0.07)($0.08)Q2 20251($0.07)($0.07)($0.07)Q3 20251($0.08)($0.08)($0.08)Q4 20251($0.07)($0.07)($0.07)FY 20255($0.31)($0.29)($0.30)ONCY Earnings Date and InformationOncolytics Biotech last announced its quarterly earnings data on March 7th, 2024. The reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.11) by $0.07. Oncolytics Biotech has generated ($0.30) earnings per share over the last year (($0.30) diluted earnings per share). Earnings for Oncolytics Biotech are expected to decrease in the coming year, from ($0.29) to ($0.32) per share. Oncolytics Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Oncolytics Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024Estimated)------- 3/7/2024Q4 2023($0.11)($0.04)+$0.07($0.04)--11/3/2023Q3 2023($0.07)($0.10)($0.03)($0.10)-- 8/14/2023Q2 2023($0.09)($0.09)-($0.09)-- 5/5/2023Q1 2023($0.07)($0.07)-($0.07)--3/3/2023Q4 2022($0.05)($0.10)($0.05)($0.10)--11/7/2022Q3 2022($0.09)($0.06)+$0.03($0.06)-- Get the Latest News and Ratings for ONCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.09)($0.07)+$0.02($0.07)--5/5/2022Q1 2022($0.13)($0.09)+$0.04($0.09)--3/3/2022Q4 2021($0.14)($0.11)+$0.03($0.11)--11/5/2021Q3 2021($0.11)($0.07)+$0.04($0.07)-- 8/6/2021Q2 2021($0.10)($0.11)($0.01)($0.11)-- Oncolytics Biotech Earnings - Frequently Asked Questions When is Oncolytics Biotech's earnings date? Oncolytics Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on ONCY's earnings history. Did Oncolytics Biotech beat their earnings estimates last quarter? In the previous quarter, Oncolytics Biotech (NASDAQ:ONCY) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.07. Learn more on analysts' earnings estimate vs. ONCY's actual earnings. How much profit does Oncolytics Biotech generate each year? Oncolytics Biotech (NASDAQ:ONCY) has a recorded net income of -$20.56 million. ONCY has generated -$0.30 earnings per share over the last four quarters. What is Oncolytics Biotech's EPS forecast for next year? Oncolytics Biotech's earnings are expected to decrease from ($0.29) per share to ($0.32) per share in the next year. More Earnings Resources from MarketBeat Related Companies: LifeVantage Earnings Results Vaccitech Earnings Results Chimerix Earnings Results Barinthus Biotherapeutics Earnings Results Spero Therapeutics Earnings Results Milestone Pharmaceuticals Earnings Results Annovis Bio Earnings Results ProPhase Labs Earnings Results YS Biopharma Earnings Results Q32 Bio Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:ONCY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold4 Cryptos BETTER than BitcoinTrue Market InsidersDoes this make you sick?Allegiance GoldBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.